| Health Net Comm & Medi-Cal Plan | Genetic Teseting for Nutrition and Metabolism | 2026-01-01 |
| Health Net Comm & Medi-Cal Plan | Genetic Testing for Oncology Cancer Screening and Surveillance | 2026-01-01 |
| Health Net Comm & Medi-Cal Plan | Genetic Testing for Respiratory | 2026-01-01 |
| Sunshine Health Clinical Policy | Home Delivered Meals (Expanded benefit) | 2026-01-01 |
| Ambetter Health Texas Superior Marketplace Clinical | POLICYTITLE | 2026-01-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Hyaluronate Derivatives (Viscosupplementation) | 2026-01-01 |
| Ambetter Health Texas Superior Marketplace Clinical | D. Centene clinical policy | 2026-01-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | Hyaluronate Derivatives (Viscosupplementation) | 2026-01-01 |
| Ambetter Health Texas Wellcare Allwell Medicare Clinical | D. Centene clinical policy | 2026-01-01 |
| UHC UMR Medical and Drug | FcRn Blockers (Rystiggo®, Vyvgart®, & Vyvgart Hytrulo®) – Commercial Medical Benefit Drug Policy | 2026-01-01 |